FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:245-253 July 23, 1998 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

When bleeding is the consequence of a specific defect of hemostasis, the goal of treatment is to correct the defect. A typical example is the replacement of factor VIII by transfusion in patients with hemophilia. Specific treatment may be impossible, however, because bleeding may result from multiple defects or because no cause can be identified. In such situations, nontransfusional drugs that help to stop bleeding are indicated.¹ These drugs may also be indicated for patients who refuse blood transfusion or for those who undergo surgical procedures associated with large blood losses necessitating many transfusions of donated blood. Many nontransfusional hemostatic . . . [Full Text of this Article]

Antifibrinolytic Amino Acids

Primary Menorrhagia

Gastrointestinal Bleeding

Bleeding in the Urinary Tract

Oral Bleeding in Congenital and Acquired Coagulation Disorders

Bleeding in Patients with Thrombocytopenia

Bleeding after Thrombolytic Treatment

Reducing Blood Loss during Cardiac Surgery

Joint Replacement

Orthotopic Liver Transplantation

Side Effects

Aprotinin

Cardiac Surgery

Orthotopic Liver Transplantation

Side Effects

Desmopressin

Congenital Bleeding Disorders

Acquired Bleeding Disorders

Cirrhosis

Reducing Blood Loss during Surgery

Side Effects

Hemostatic Drugs as Prophylaxis in Patients Undergoing Cardiac Surgery

Conjugated Estrogens

Conclusions

Source Information

From the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Istituto di Ricovero e Cura a Carattere Scientifico Maggiore Hospital, and the University of Milan, Milan, Italy.

Address reprint requests to Dr. Mannucci at Via Pace 9, 20122 Milan, Italy.

References

This article has been cited by other articles:

• Mengistu, A. M., Rohm, K. D., Boldt, J., Mayer, J., Suttner, S. W., Piper, S. N. (2008). The Influence of Aprotinin and Tranexamic Acid on Platelet Function and Postoperative Blood Loss in Cardiac Surgery. Anesth. Analg. 107: 391-397 [Abstract] [Full Text]  
• Tinmouth, A. T. MD MSc, McIntyre, L. A. MD MSc, Fowler, R. A. MDCM MS (2008). Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. CMAJ 178: 49-57 [Abstract] [Full Text]  
• Levy, J. H., Tanaka, K. A., Bailey, J. M. (2008). Cardiac Surgical Pharmacology. Card Surg Adult 3: 77-110 [Full Text]  
• Bakaeen, F., Rice, D., Correa, A. M., Walsh, G. L., Vaporciyan, A. A., Putnam, J. B., Swisher, S. G., Roth, J. A., Huh, J., Chu, D., Smythe, W. R. (2007). Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis and Incidence of Complications. Ann. Thorac. Surg. 84: 982-986 [Abstract] [Full Text]  
• Mannucci, P. M., Levi, M. (2007). Prevention and Treatment of Major Blood Loss. NEJM 356: 2301-2311 [Full Text]  
• Choong, C. K., Gerrard, C., Goldsmith, K. A., Dunningham, H., Vuylsteke, A. (2007). Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes. Eur. J. Cardiothorac. Surg. 31: 834-838 [Abstract] [Full Text]  
• Awan, F., Hamadani, M. (2007). Gastrointestinal chronic graft-versus-host disease: management options. J Oncol Pharm Pract 13: 49-51 [Abstract]  
• Quiroga, T., Goycoolea, M., Panes, O., Aranda, E., Martinez, C., Belmont, S., Munoz, B., Zuniga, P., Pereira, J., Mezzano, D. (2007). High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. haematol 92: 357-365 [Abstract] [Full Text]  
• Ozgonenel, B., Rajpurkar, M., Lusher, J. M (2007). How do you treat bleeding disorders with desmopressin?. Postgrad. Med. J. 83: 159-163 [Abstract] [Full Text]  
• Mayer, S. A. (2007). Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage. Stroke 38: 763-767 [Abstract] [Full Text]  
• Patatanian, E., Fugate, S. E (2006). Hemostatic Mouthwashes in Anticoagulated Patients Undergoing Dental Extraction. The Annals of Pharmacotherapy 40: 2205-2210 [Abstract] [Full Text]  
• Mahdy, A. M., Webster, N. R. (2004). Perioperative systemic haemostatic agents. Br J Anaesth 93: 842-858 [Abstract] [Full Text]  
• Davis, M. P. (2004). Hematology in palliative medicine. AM J HOSP PALLIAT CARE 21: 445-454 [Abstract]  
• Ballen, K. K., Becker, P. S., Yeap, B. Y., Matthews, B., Henry, D. H., Ford, P. A. (2004). Autologous Stem-Cell Transplantation Can Be Performed Safely Without the Use of Blood-Product Support. JCO 22: 4087-4094 [Abstract] [Full Text]  
• Mannucci, P. M. (2004). Treatment of von Willebrand's Disease. NEJM 351: 683-694 [Full Text]  
• Carraro, M., Zennaro, C., Artero, M., Candiano, G., Ghiggeri, G. M., Musante, L., Sirch, C., Bruschi, M., Faccini, L. (2004). The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 19: 1969-1975 [Abstract] [Full Text]  
• Bombeli, T., Spahn, D. R. (2004). Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth 93: 275-287 [Abstract] [Full Text]  
• Hashem, B., Dillard, T. A. (2004). A 44-Year-Old Jehovah's Witness With Life-Threatening Anemia From Uterine Bleeding. Chest 125: 1151-1154 [Full Text]  
• Sabovic, M., Lavre, J., Vujkovac, B. (2003). Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 18: 1388-1391 [Abstract] [Full Text]  
• Paez, X., Hernandez, L. (2003). Topical Hemostatic Effect of a Common Ornamental Plant, the Geraniaceae Pelargonium zonale. J Clin Pharmacol 43: 291-295 [Abstract] [Full Text]  
• Bailey, J. M., Tanaka, K. A., Levy, J. H. (2003). Cardiac Surgical Pharmacology. Card Surg Adult 2: 85-118 [Full Text]  
• Mayer, S. A. (2003). Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage. Stroke 34: 224-229 [Abstract] [Full Text]  
• Kovesi, T., Royston, D. (2002). Editorial I: Is there a bleeding problem with platelet-active drugs?. Br J Anaesth 88: 159-163 [Full Text]  
• Beholz, S., Liu, J., Thoelke, R., Spiess, C, Konertz, W. (2001). Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement. Perfusion 16: 485-489 [Abstract]  
• Levy, J. H. (2001). Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann. Thorac. Surg. 72: S1814-1820 [Abstract] [Full Text]  
• Wang, G. J., Hungerford, D. S., Savory, C. G., Rosenberg, A. G., Mont, M. A., Burks, S. G., Mayers, S. L., Spotnitz, W. D. (2001). Use of Fibrin Sealant to Reduce Bloody Drainage and Hemoglobin Loss After Total Knee Arthroplasty : A Brief Note on a Randomized Prospective Trial. JBJS 83: 1503-1505 [Abstract] [Full Text]  
• Mannucci, P. M. (2001). How I treat patients with von Willebrand disease. Blood 97: 1915-1919 [Abstract] [Full Text]  
• Klepfish, A., Berrebi, A., Schattner, A. (2001). Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia. Arch Intern Med 161: 767-767 [Full Text]  
• Haziot, A., Hijiya, N., Gangloff, S. C., Silver, J., Goyert, S. M. (2001). Induction of a Novel Mechanism of Accelerated Bacterial Clearance by Lipopolysaccharide in CD14-Deficient and Toll-Like Receptor 4-Deficient Mice. J. Immunol. 166: 1075-1078 [Abstract] [Full Text]  
• Aledort, L. M., Green, D., Teitel, J. M. (2001). Unexpected Bleeding Disorders. ASH Education Book 2001: 306-321 [Abstract] [Full Text]  
• Casati, V., Guzzon, D., Oppizzi, M., Bellotti, F., Franco, A., Gerli, C., Cossolini, M., Torri, G., Calori, G., Benussi, S., Alfieri, O. (2000). Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: Effects on perioperative bleeding and allogeneic transfusions. J. Thorac. Cardiovasc. Surg. 120: 520-527 [Abstract] [Full Text]  
• Jovanovic, S, Hansbro, S D, Munsch, C M, Cross, M H (2000). Redo cardiac surgery in a Jehovah's Witness, the importance of a multidisciplinary approach to blood conservation. Perfusion 15: 251-255 [Abstract]  
• Rao, A. K., Gabbeta, J. (2000). Congenital Disorders of Platelet Signal Transduction. Arterioscler. Thromb. Vasc. Bio. 20: 285-289 [Full Text]  
• Savarese, D., Waitkus, H., Stewart, F. M., Callery, M. (1999). Bloodless Medicine and Surgery. J Intensive Care Med 14: 20-33  
• Khuri, S. F., Healey, N., MacGregor, H., Barnard, M. R., Szymanski, I. O., Birjiniuk, V., Michelson, A. D., Gagnon, D. R., Valeri, C. R. (1999). COMPARISON OF THE EFFECTS OF TRANSFUSIONS OF CRYOPRESERVED AND LIQUID-PRESERVED PLATELETS ON HEMOSTASIS AND BLOOD LOSS AFTER CARDIOPULMONARY BYPASS. J. Thorac. Cardiovasc. Surg. 117: 172-185 [Abstract] [Full Text]